← Back to headlines
Abivax Shares Pare Gains After Denying AstraZeneca Speculation
Abivax stock saw its gains reduced after the company denied speculation regarding a potential deal or collaboration with AstraZeneca.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
